Everything below concerns cold chain. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-03-22. Where a claim depends on a specific study, the study is described rather than over-claimed.
GLP-1 receptors are expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises cyclic AMP, enhances glucose-dependent insulin secretion, and suppresses glucagon release when blood glucose is high. Effects on gastric emptying and on hypothalamic appetite circuits reduce energy intake. Because insulin release remains glucose-dependent, the risk of hypoglycemia is low when the drug is used alone. The precise contribution of each pathway to body weight change in humans remains an area of active investigation.
Clinical studies of semaglutide generally measure glycated hemoglobin, fasting plasma glucose, body weight, and composite cardiovascular endpoints. The SUSTAIN program enrolled adults with type 2 diabetes, while the STEP program focused on obesity without diabetes. Administration follows a stepwise escalation schedule designed to limit gastrointestinal effects during the first weeks. Reported outcomes include mean percentage weight change, the proportion of participants reaching defined weight-loss thresholds, and rates of nausea, vomiting, and diarrhea. Long-term data on durability after treatment stops are still limited and remain a topic of ongoing research.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, developed by Novo Nordisk and first approved in 2017 for type 2 diabetes. It belongs to the incretin mimetic class, a group of agents that reproduce the glucose-dependent actions of endogenous GLP-1. The molecule was engineered to resist degradation by dipeptidyl peptidase-4 and to bind serum albumin, extending its half-life from minutes to roughly one week. Approval for chronic weight management followed in 2021, based on large cardiovascular and obesity outcome trials.
As a peptide, semaglutide is sensitive to conditions that break amide bonds or modify side chains. Deamidation of asparagine and glutamine residues, oxidation of methionine and tryptophan, and non-covalent aggregation are the main degradation routes described in published stability work. Rate depends strongly on pH, buffer species, ionic strength, temperature and exposure to light. Formulators therefore choose a defined solution pH and often add excipients such as phosphate buffer, propylene glycol and phenol, each of which plays a separate role in pH control, tonicity or preservation.
Storage guidance for the finished injectable product distinguishes the unused state from the in-use state. Before first use, pens are kept refrigerated between 2 and 8 degrees Celsius, protected from light, and never frozen, since freezing can disrupt the peptide or the device. After first use, label instructions in several markets permit storage at room temperature up to about 30 degrees Celsius for a limited number of days. Solid research-grade material is normally held at or below minus 20 degrees Celsius, often with desiccant, and allowed to equilibrate before opening.
Quantification and purity assessment rely on separation methods coupled to optical or mass detection. Reversed-phase high-performance liquid chromatography resolves the intact peptide from related impurities and is the standard assay technique. Size-exclusion chromatography measures aggregates, while ion-exchange chromatography separates charge variants produced by deamidation. Mass spectrometry confirms identity and detects mass shifts of a few daltons. In biological matrices, liquid chromatography with tandem mass spectrometry is often used because immunoassays can cross-react with endogenous GLP-1 or with circulating fragments.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C187H291N45O59 | Peptide backbone with a C18 fatty diacid side chain |
| Molecular weight | Approximately 4113 Da | Consistent with a 31-residue peptide plus linker |
| Appearance | White to off-white powder | Lyophilized solid; hygroscopic if left open |
| Solubility class | Sparingly soluble to soluble in water | Varies with pH and ionic strength |
| Typical analytical method | Reversed-phase HPLC with UV detection | Often paired with mass spectrometry for identity |
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1, a hormone released from intestinal L-cells after food intake. It contains 31 amino acids and differs from native GLP-1 through modifications that slow enzymatic breakdown. The peptide was developed to extend the short circulating half-life of endogenous GLP-1, which is measured in minutes. Researchers introduced the compound in the early 2010s. Two backbone changes and a fatty acid side chain define its structure, distinguishing it from earlier GLP-1 receptor agonists.
The compound binds the GLP-1 receptor on pancreatic beta cells and other tissues, activating a G-protein signaling cascade that raises intracellular cyclic AMP. This action increases glucose-dependent insulin secretion when blood glucose is elevated, while binding also slows gastric emptying and reduces glucagon release. In the central nervous system, receptor activation in the hypothalamus and brainstem contributes to reduced appetite. The fatty acid chain binds albumin, which protects the peptide from renal filtration and enzymatic degradation. This albumin binding is central to its extended circulation time.
Native GLP-1 is degraded rapidly by dipeptidyl peptidase-4. Semaglutide resists this cleavage because alanine at position 8 is replaced by alpha-aminoisobutyric acid. A second substitution at position 34 introduces arginine, which further stabilizes the peptide. The most distinctive modification is a spacer and C18 fatty diacid attached at lysine 26, enabling strong albumin affinity. These three changes together produce a half-life measured in days rather than minutes, and the same structural logic underlies other long-acting analogs in this class.
Lyophilized peptide material is typically stored at or below -20 °C, with -80 °C used for longer-term archives. Vials should remain sealed and desiccated because moisture promotes aggregation and hydrolysis. Repeated freeze-thaw cycles are avoided since they can alter peptide conformation and reduce recovery. Once reconstituted, solutions are generally kept at 2-8 °C and used within a defined window. Stability beyond those windows depends on buffer composition and concentration, and exact limits are product-specific rather than universal.
Identity and purity are assessed with reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities by hydrophobicity. Mass spectrometry confirms molecular weight and detects truncation or modification products. Peptide mapping after enzymatic digestion verifies the amino acid sequence. Quantitation is often performed by LC-MS/MS or by immunoassay, and the two approaches can give different values because they measure different things. Method validation parameters such as accuracy, precision, and limit of quantitation are reported alongside results.
Receptor activation occurs at GLP-1 receptors distributed across pancreatic islets, the hypothalamus, and the gastrointestinal tract. Binding triggers G protein signaling that raises cyclic AMP and enhances glucose-dependent insulin release. Because the effect depends on prevailing glucose levels, insulin secretion does not rise when blood sugar is already low. Signaling in the brain and gut also influences appetite and gastric emptying, which is why the compound appears in both metabolic and weight-related research literature.
Development began in the early 2010s with the goal of extending GLP-1 activity beyond the brief window achieved by native peptide infusion. The earliest approved formulation was a subcutaneous injection given once weekly. A later oral tablet pairs the peptide with an absorption enhancer, sodium N-(8-[2-hydroxybenzoyl] amino) caprylate, usually shortened to SNAC. That carrier lowers local pH and helps the peptide cross gastric tissue. Both routes deliver the same active molecule.
=== Sardinia, Italy === Depleted uranium has been named as a possible contributing factor to a high incidence of birth defects and cancer near the Salto di Quirra weapons testing range on the Italian island of Sardinia.
== Mechanism of action == Empagliflozin is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), which is found almost exclusively in the proximal tubules of nephronic components in the kidneys. SGLT-2 accounts for about 90 percent of glucose reabsorption into the blood. Blocking SGLT-2 reduces blood glucose by blocking glucose reabsorption in the kidney and thereby excreting glucose (i.e., blood sugar) via the urine. Of all the SGLT-2 Inhibitors currently available, empagliflozin has the highest degree of selectivity for SGLT-2 over SGLT-1, SGLT-4, SGLT-5 and SGLT-6.
In 2023, Cambrex acquired the Waltham-headquartered chemical process development services provider, Snapdragon Chemistry. In 2024, Cambrex expanded Q1 Scientific with new state-of-the-art, temperature-controlled and monitored, stability storage facility in Durham, North Carolina. In 2025, Cambrex sold its large-scale drug product business unit to Noramco, including its two sites in Whippany, NJ and Mirabel, Quebec.
Sources: en.wikipedia.org
Russell Brand's live tour is postponed, as police investigate a further allegation of sexual assault by the celebrity, dating back to 2003. The UK government announces that Post Office workers who had wrongful convictions for false accounting and theft overturned will each be offered £600,000 in compensation. 19 September The UK government announces that commissioners will be appointed to oversee the running of Birmingham City Council following its recent financial troubles. The Scottish Government begins its legal challenge against Westminster over the UK government's decision to block the controversial Gender Recognition Reform (Scotland) Bill. 20 September Data released by the Office for National Statistics show that inflation fell from 6.8% in July to 6.7% in August, something that is attributed to a fall in food prices. Sunak announces a major rethink of the UK government's strategy to achieve net zero carbon output in the UK by 2050, including a delay in banning the sale of new petrol and diesel cars from 2030 to 2035. 21 September The Bank of England holds interest rates at 5.25% after inflation for August was lower than expected. Five Bulgarian nationals suspected of spying for Russia are to be charged with conspiracy to conduct espionage. Charles III addresses the French Senate during his state visit to France. News Corp chairman Rupert Murdoch announces his retirement and plan to hand over his businesses to his son Lachlan. Murdoch additionally owned the American broadcaster Fox and formerly Sky Group.
=== 2020s === 2020: The Nigerian Academy of Science elected epidemiologist/parasitologist Ekanem Braide as its first female president. 2020: Brazilian Scientist and Researcher Jaqueline Goes de Jesus, sequenced COVID-19 genome in 12 hours. 2020: Biochemists Jennifer Doudna (American) and Emmanuelle Charpentier (French) received the Nobel Prize in Chemistry for their work on CRISPR genome editing tool. 2020: American astronomer Andrea M. Ghez received the Nobel Prize in Physics for the discovery of a supermassive compact object. 2020: German-Turkish scientist Özlem Türeci is the co-founder and chief medical officer of BioNTech. Her team developed BNT162b2 (tozinameran (INN)), commonly known as the Pfizer–BioNTech COVID-19 vaccine. 2020: British vaccinologist Sarah Gilbert leads the development and testing of a vaccine which becomes the Oxford–AstraZeneca COVID-19 vaccine. 2021: Catherine Heymans was appointed as the first female Astronomer Royal for Scotland. 2022: American chemist Carolyn R. Bertozzi received the Nobel Prize in Chemistry for her development of Bioorthogonal chemistry. 2023: Australian geomicrobiologist Jillian Banfield became the first female recipient of the van Leeuwenhoek Medal, which she received for her studies of complex microbial communities and their interaction with the environment. 2023: Hungarian American scientist Katalin Kariko receives Noble prize in Physiology or Medicine with Drew Weissman for their discoveries on nucleoside base modifications that enabled the development of effective mRNA vaccines.
=== Mi === August Michaelis (1847–1916), German chemist who discovered the Michaelis–Arbuzov reaction Leonor Michaelis (1875–1949), German biochemist and physical chemist known for fundamental advances in enzyme chemistry Hartmut Michel (born 1948), German biochemist, 1988 Nobel Prize in Chemistry for determination of the first crystal structure of an integral membrane protein Huang Minlon (1889–1979), Chinese chemist, pioneer of modern pharmaceutical industries in China Stanley Miller (1930–2007), American chemist, best known for the Miller–Urey experiment Eugène Millon (1812–1867), French military chemist and physician who discovered the reaction of mercury and nitric acid with egg albumen David P. Mills (PhD 2007), British chemist who investigates lanthanide and actinide f-block elements Luis E. Miramontes (1925–2004), Mexican co-inventor of the combined oral contraceptive pill Peter D. Mitchell (1920–1992), British biochemist known for the theory of chemiosmosis, 1978 Nobel Prize in Chemistry Eilhardt Mitscherlich (1794–1863), German chemist, remembered for the law of isomorphism. Alexander Mitscherlich (1836–1918), German chemist known for discovering crystallographic isomorphism
Sources: en.wikipedia.org
=== Governance style === Known as a very secretive leader, little is known publicly about how Xi makes political decisions, or how he came to power. Xi's speeches generally get released months or years after they are made. Xi has also never given a press conference since becoming paramount leader, except in rare joint press conferences with foreign leaders. The Wall Street Journal reported that Xi prefers micromanaging in governance, in contrast to previous leaders such as Hu Jintao who left details of major policies to lower-ranking officials. Reportedly, ministerial officials try to get Xi's attention in various ways, with some creating slide shows and audio reports. The Wall Street Journal also reported that Xi created a performance-review system in 2018 to give evaluations on officials on various measures, including loyalty. According to The Economist, Xi's orders have generally been vague, leaving lower level officials to interpret his words. Chinese state media Xinhua News Agency said that Xi "personally reviews every draft of major policy documents" and "all reports submitted to him, no matter how late in the evening, were returned with instructions the following morning." With regard to behavior of Communist Party members, Xi emphasizes the "Two Musts" (members must not be arrogant or rash and must keep their hard-working spirit) and the "Six Nos" (members must say no to formalism, bureaucracy, gift-giving, luxurious birthday celebrations, hedonism, and extravagance).
having an acceptable treatment protocol in place that changes the outcome for patients diagnosed early with the disease an understanding of the condition's natural history an understanding about who will be treated as a patient a screening test that is reliable for both affected and unaffected patients and is acceptable to the public As diagnostic techniques have progressed, debates have arisen as to how screening programs should adapt. Tandem mass spectrometry has greatly expanded the potential number of diseases that can be detected, even without satisfying all of the other criteria used for making screening decisions. Duchenne muscular dystrophy is a disease that has been added to screening programs in several jurisdictions around the world, despite the lack of evidence as to whether early detection improves the clinical outcome for a patient.
== Reception == Chain Reaction received negative reviews. The film holds an 18% rating on Rotten Tomatoes based on 33 reviews, with the site's critical consensus stating, "Ironic given the scientific breakthrough at the story's core, Chain Reaction is a man-on-the-run thriller that mostly sticks to [the] generic formula." Audiences polled by CinemaScore gave the film an average grade of "C+" on an A+ to F scale. Roger Ebert gave the film two and a half stars out of four, writing: "By movie's end, I'd seen some swell photography and witnessed some thrilling chase scenes, but when it came to understanding the movie, I didn't have a clue." Jeff Millar of the Houston Chronicle wrote: "The narrative is very complex, but what's on the screen is little more than generic, non-narrative-specific, guy-being-chased stuff". Conversely, Edward Guthmann of the San Francisco Chronicle felt the film was one of the summer's best movies, writing: "[Chain Reaction] has better acting, better writing, more spectacular chase sequences and more genuine drama than all of this summer's blockbusters." Chain Reaction and its cast were nominated for one award, with Keanu Reeves being nominated for the Razzie for Worst Actor, which was won by both Tom Arnold and Pauly Shore. Chain Reaction debuted in fourth place at the box office behind A Time to Kill, Independence Day and Matilda, collecting a total of $7.5 million during its opening weekend. The film grossed just over USD$60.2 million worldwide. Reeves has since expressed regret about Chain Reaction, blaming script changes.
Sources: en.wikipedia.org
It is given either as a once-weekly subcutaneous injection or as an oral tablet taken once daily. The two forms use different absorption strategies, so they are not interchangeable on a milligram-for-milligram basis.
Structural modifications, including a fatty acid side chain and non-natural amino acid substitutions, slow enzymatic breakdown and promote albumin binding. These changes support once-weekly dosing rather than twice-daily administration.
The pathways involving insulin, glucagon, gastric emptying, and appetite signaling are well described. How much each pathway contributes to weight reduction in a given person is not fully established.
Ice formation concentrates solutes and can mechanically stress the peptide or damage the delivery device. Thawing afterwards may leave aggregates that are not visible to the eye. Refrigeration keeps the solution above its freezing point while slowing chemical degradation.